Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Estee Gold Feet Tbk. (EURO) vs Indofarma Tbk. (INAF)

Estee Gold Feet Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Estee Gold Feet Tbk. dan Indofarma Tbk.: Estee Gold Feet Tbk. diperdagangkan di Rp1.400 (kapitalisasi pasar 3,68 T, volume 24 jam 168,3 rb), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Estee Gold Feet Tbk. jauh lebih besar — sekitar 9,4× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

EUROINAF
Kapitalisasi Pasar
3,68 T390,51 M
Volume
168,3 rb
Lot
1,68 rb
Perputaran
233,12 jt
Harga Rata-rata
1.385,12
Nilai Transaksi
233,12 jt
Harga Ekuilibrium Indikatif
1.400
Volume Ekuilibrium Indikatif
71

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EURO
Lihat detail
INAF
Lihat detail

Tentang Estee Gold Feet Tbk.

PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.

Selengkapnya di halaman EURO

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF